Results 51 to 60 of about 3,265,867 (293)

The Role of Dual Antiplatelet in Stent-Assisted Coiling in Wide-Neck Aneurysm

Aksona, 2023
Highlight: • Dual antiplatelet is the gold standard for endovascular treatment of wide-neck aneurysms. • The role of dual antiplatelet is to prevent stent thrombosis after treatment.
Ricky Gusanto Kurniawan, Bambang Tri Prasetyo, Beny Rilianto, Abrar Arham   +3 more
doaj   +1 more source

Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes [PDF]

, 2020
To investigate the effect of ticagrelor monotherapy after 1-month dual antiplatelet therapy (DAPT) or conventional DAPT in patients with or without acute coronary syndrome (ACS) in the GLOBAL LEADERS Adjudication Sub-Study (GLASSY)
Christian Hamm, Anna Franzone, Jüni, Peter, Eugène P. McFadden, Hamm, Christian, Leonardi, Sergio, Mattia Branca, Steg, Philippe Gabriel, McFadden, Eugène P, Vranckx, Pascal, Sergio Leonardi, Heg, Dik, Windecker, Stephan, Pascal Vranckx, Philippe Gabriel Steg, Branca, Mattia, Piccolo, Raffaele, Marco Valgimigli., McFadden, Eugène P., Stephan Windecker, Franzone, Anna, Patrick W Serruys, Dik Heg, Peter Jüni, Serruys, Patrick W., Raffaele Piccolo, Serruys, Patrick W, Valgimigli, Marco   +27 more
core   +3 more sources

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

American Journal of Hematology, EarlyView.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas, Nichola Cooper, Vickie McDonald, Karina Yazdanbakhsh, Wilma Barcellini   +4 more
wiley   +1 more source

Standardization of measurement and reporting of medication adherence using the TEN‐SPIDERS tool for claims data

British Journal of Clinical Pharmacology, EarlyView.
This study provides the first open‐source tool to implement the complete TEN‐SPIDERS framework in linked datasets for the determination of the PDC for medication adherence. The TEN‐SPIDERS tool enables transparent, reproducible medication adherence research through automated reporting of all calculation parameters and flexible customization options ...
Adam C. Livori, Tzu‐Yung Kuo, Jenni Ilomäki, Monique F. Kilkenny, Stella Talic, Zanfina Ademi, J. Simon Bell, Jedidiah I. Morton, Lachlan L. Dalli   +8 more
wiley   +1 more source

Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report

JA Clinical Reports, 2019
Background Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial ...
Eriko Takeyama, Aiko Wada, Eizo Amano, Hiromi Shibuya   +3 more
doaj   +1 more source

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

Frontiers in Cardiovascular Medicine, 2022
Dual antiplatelet therapy (DAPT) for 6–12 months, followed by lifelong aspirin monotherapy is considered an effective standard therapy for the prevention of thrombo-ischemic events in patients with acute and chronic coronary syndrome (ACS, CCS ...
Marie Muthspiel, Christoph C. Kaufmann, Achim Leo Burger, Benjamin Panzer, Freek W. A. Verheugt, Kurt Huber, Kurt Huber   +6 more
doaj   +1 more source

Dual Antiplatelet Therapy and Bleeding-Related Deaths

Journal of the American College of Cardiology, 2017
We read with interest the report by Palmerini et al. [(1)][1], who found that the risk of death from bleeding was related to the duration of dual antiplatelet therapy (DAPT), but we have questions about separating DAPT duration into the customary binary categories of “short” versus “long.”
John A, Bittl, Yulei, He
openaire   +2 more sources

Mobile health interventions to improve adherence to oral anticoagulant treatment: A systematic review and critical analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Non‐adherence to oral anticoagulants (OACs) is associated with significant morbidity and mortality. Mobile health (mHealth) interventions have been used to improve medication adherence across the three phases of initiation, implementation and persistence.
Non Davies, Elin Haf Davies, Dyfrig A. Hughes   +2 more
wiley   +1 more source

Clinical benefits of prolonged dual antiplatelet therapy following complex percutaneous coronary intervention

, 2019
AIMS: Prolonged dual antiplatelet therapy (DAPT) requires consideration of both reduced thrombotic events and increased bleeding risk. The associated subtle balance between the benefits and harms depends upon patient's clinical factors and complexity of ...
Mridha, Naim, Singh, Kuljit, Deloshaan Subhaharan, Kuljit Singh, Subhaharan, Deloshaan, Naim Mridha   +5 more
core   +1 more source

Triple Therapy or Triple Threat: An Analysis of Triple Antiplatelet Therapy Compared to Dual Antiplatelet Therapy [PDF]

, 2019
Triple antiplatelet therapy (TAPT, or triple therapy), is an oral medication regimen designed to reduce the risk of major cardiovascular events. It consists of aspirin, clopidogrel or an alternative, and an oral anticoagulant (OAC).
Cwikla, Isabel E., Horvath, Kara C., Hilverding, Austin, Gollmar, Elaina, Petersen, Erin   +4 more
core   +1 more source